Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure

Abstract

ObjectivesQuality indicators (QIs) assessing the appropriateness of antibiotic use are essential to identify targets for improvement and guide antibiotic stewardship interventions. The aim of this study was to develop a set of QIs for the outpatient setting from a global perspective.MethodsA systematic literature review was performed by searching MEDLINE and relevant web sites in order to retrieve a list of QIs. These indicators were extracted from published trials, guidelines, literature reviews or consensus procedures. This evidence-based set of QIs was evaluated by a multidisciplinary, international group of stakeholders using a RAND-modified Delphi procedure, using two online questionnaires and a face-to-face meeting between them. Stakeholders appraised the QIs’ relevance using a nine-point Likert scale. This work is part of the DRIVE-AB project.ResultsThe systematic literature review identified 43 unique QIs, from 54 studies and seven web sites. Twenty-five stakeholders from 14 countries participated in the consensus procedure. Ultimately, 32 QIs were retained, with a high level of agreement. The set of QIs included structure, process and outcome indicators, targeting both high- and middle- to low-income settings. Most indicators focused on general practice, addressing the common indications for antibiotic use in the community (particularly urinary and respiratory tract infections), and the organization of healthcare facilities. Twelve indicators specifically addressed outpatient parenteral antimicrobial therapy (OPAT).ConclusionsWe identified a set of 32 outpatient QIs to measure the appropriateness of antibiotic use. These QIs can be used to identify targets for improvement and to evaluate the effects of antibiotic stewardship interventions.

Treatment of Cystitis by Hungarian General Practitioners: A Prospective Observational Study

“…As antibiotics are unambiguously superior to placebo for urinary tract infections (Falagas et al, 2009), antibiotic use can be considered optimal in every LUTI case. The rate of antibiotic prescribing for LUTI in this study (over 90%) meets international quality indicators (Adriaenssens et al, 2011;Le Marechal et al, 2018) and correlates well with findings of antibiotic utilisation studies for other countries, except the Netherlands and Latvia where antibiotic prescription rate is reported to be less than 60% and around 70% in acute urinary tract infections in adults, respectively (Martinez et al, 2007;Llor et al, 2011;Butler et al, 2017). The lower prescription rate in these countries may be explained by the more frequent application of delayed or conditional antibiotic prescribing (Gagyor et al, 2012;Gagyor et al, 2015).…”

Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future

“…More recently, an international multidisciplinary group consolidated potential QIs for patients in ambulatory care particularly those with respiratory tract infections. These included both structure and process measures (Box 1) 351 .…”

Variation in antibiotic use among and within different settings: a systematic review

“… 1 Further systematic reviews in the context of DRIVE-AB aimed to specifically assess the definition of responsible use of antibiotics 14 and to assess quantity metrics and quality indicators for antimicrobial use in the inpatient 15 , 16 and outpatient settings. 17 , 18 …”